Stockreport

NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences

NewcelX Ltd. - Ordinary Shares  (NCEL) 
PDF Reinforces strategic focus on Type 1 Diabetes cell therapy and highlights expansion of Scientific Advisory Board and leadership teamZURICH, Jan. 29, 2026 /PRNewswire/ -- [Read more]